FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020361785> ?p ?o ?g. }

• W2020361785 abstract "Effective malaria control has successfully reduced the malaria burden in many countries, but to eliminate malaria, these countries will need to further improve their control efforts. Here, a malaria control programme was critically evaluated in a very low-endemicity Thai-Myanmar border population, where early detection and prompt treatment have substantially reduced, though not ended, Plasmodium falciparum transmission, in part due to carriage of late-maturing gametocytes that remain post-treatment. To counter this effect, the WHO recommends the use of a single oral dose of primaquine along with an effective blood schizonticide. However, while the effectiveness of primaquine as a gametocidal agent is widely documented, the mismatch between primaquine's short half-life, the long-delay for gametocyte maturation and the proper timing of primaquine administration have not been studied.Mathematical models were constructed to simulate 8-year surveillance data, between 1999 and 2006, of seven villages along the Thai-Myanmar border. A simple model was developed to consider primaquine pharmacokinetics and pharmacodynamics, gametocyte carriage, and infectivity.In these populations, transmission intensity is very low, so the P. falciparum parasite rate is strongly linked to imported malaria and to the fraction of cases not treated. Given a 3.6-day half-life of gametocyte, the estimated duration of infectiousness would be reduced by 10 days for every 10-fold reduction in initial gametocyte densities. Infectiousness from mature gametocytes would last two to four weeks and sustain some transmission, depending on the initial parasite densities, but the residual mature gametocytes could be eliminated by primaquine. Because of the short half-life of primaquine (approximately eight hours), it was immediately obvious that with early administration (within three days after an acute attack), primaquine would not be present when mature gametocytes emerged eight days after the appearance of asexual blood-stage parasites. A model of optimal timing suggests that primaquine follow-up approximately eight days after a clinical episode could further reduce the duration of infectiousness from two to four weeks down to a few days. The prospects of malaria elimination would be substantially improved by changing the timing of primaquine administration and combining this with effective detection and management of imported malaria cases. The value of using primaquine to reduce residual gametocyte densities and to reduce malaria transmission was considered in the context of a malaria transmission model; the added benefit of the primaquine follow-up treatment would be relatively large only if a high fraction of patients (>95%) are initially treated with schizonticidal agents.Mathematical models have previously identified the long duration of P. falciparum asexual blood-stage infections as a critical point in maintaining malaria transmission, but infectiousness can persist for two to four weeks because of residual populations of mature gametocytes. Simulations from new models suggest that, in areas where a large fraction of malaria cases are treated, curing the asexual parasitaemia in a primary infection, and curing mature gametocyte infections with an eight-day follow-up treatment with primaquine have approximately the same proportional effects on reducing the infectious period. Changing the timing of primaquine administration would, in all likelihood, interrupt transmission in this area with very good health systems and with very low endemicity." @default.
• W2020361785 created "2016-06-24" @default.
• W2020361785 creator A5000746138 @default.
• W2020361785 creator A5001324943 @default.
• W2020361785 creator A5011589199 @default.
• W2020361785 creator A5013850508 @default.
• W2020361785 creator A5037956991 @default.
• W2020361785 creator A5042225951 @default.
• W2020361785 creator A5046778641 @default.
• W2020361785 creator A5060343662 @default.
• W2020361785 creator A5086768294 @default.
• W2020361785 date "2009-07-15" @default.
• W2020361785 modified "2023-10-14" @default.
• W2020361785 title "Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations" @default.
• W2020361785 cites W1488140862 @default.
• W2020361785 cites W1490125251 @default.
• W2020361785 cites W1622422817 @default.
• W2020361785 cites W1967940959 @default.
• W2020361785 cites W1968101672 @default.
• W2020361785 cites W1983736456 @default.
• W2020361785 cites W1993435564 @default.
• W2020361785 cites W1997246997 @default.
• W2020361785 cites W2017080914 @default.
• W2020361785 cites W2029237652 @default.
• W2020361785 cites W2033907336 @default.
• W2020361785 cites W2039227742 @default.
• W2020361785 cites W2040795754 @default.
• W2020361785 cites W2047506346 @default.
• W2020361785 cites W2049122105 @default.
• W2020361785 cites W2058857662 @default.
• W2020361785 cites W2067428749 @default.
• W2020361785 cites W2076029682 @default.
• W2020361785 cites W2085154693 @default.
• W2020361785 cites W2091684277 @default.
• W2020361785 cites W2092267237 @default.
• W2020361785 cites W2101847661 @default.
• W2020361785 cites W2105468816 @default.
• W2020361785 cites W2111813303 @default.
• W2020361785 cites W2112977667 @default.
• W2020361785 cites W2113510423 @default.
• W2020361785 cites W2119009518 @default.
• W2020361785 cites W2120463581 @default.
• W2020361785 cites W2124136203 @default.
• W2020361785 cites W2130853973 @default.
• W2020361785 cites W2131545842 @default.
• W2020361785 cites W2134344980 @default.
• W2020361785 cites W2136837443 @default.
• W2020361785 cites W2141190197 @default.
• W2020361785 cites W2141519129 @default.
• W2020361785 cites W2148082032 @default.
• W2020361785 cites W2148420565 @default.
• W2020361785 cites W2159056342 @default.
• W2020361785 cites W2168928027 @default.
• W2020361785 cites W2170682092 @default.
• W2020361785 cites W2176007704 @default.
• W2020361785 cites W2231736709 @default.
• W2020361785 cites W2259706633 @default.
• W2020361785 doi "https://doi.org/10.1186/1475-2875-8-159" @default.
• W2020361785 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2718908" @default.
• W2020361785 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19604346" @default.
• W2020361785 hasPublicationYear "2009" @default.
• W2020361785 type Work @default.
• W2020361785 sameAs 2020361785 @default.
• W2020361785 citedByCount "51" @default.
• W2020361785 countsByYear W20203617852012 @default.
• W2020361785 countsByYear W20203617852013 @default.
• W2020361785 countsByYear W20203617852014 @default.
• W2020361785 countsByYear W20203617852015 @default.
• W2020361785 countsByYear W20203617852016 @default.
• W2020361785 countsByYear W20203617852017 @default.
• W2020361785 countsByYear W20203617852020 @default.
• W2020361785 countsByYear W20203617852023 @default.
• W2020361785 crossrefType "journal-article" @default.
• W2020361785 hasAuthorship W2020361785A5000746138 @default.
• W2020361785 hasAuthorship W2020361785A5001324943 @default.
• W2020361785 hasAuthorship W2020361785A5011589199 @default.
• W2020361785 hasAuthorship W2020361785A5013850508 @default.
• W2020361785 hasAuthorship W2020361785A5037956991 @default.
• W2020361785 hasAuthorship W2020361785A5042225951 @default.
• W2020361785 hasAuthorship W2020361785A5046778641 @default.
• W2020361785 hasAuthorship W2020361785A5060343662 @default.
• W2020361785 hasAuthorship W2020361785A5086768294 @default.
• W2020361785 hasBestOaLocation W20203617851 @default.
• W2020361785 hasConcept C119599485 @default.
• W2020361785 hasConcept C127413603 @default.
• W2020361785 hasConcept C159047783 @default.
• W2020361785 hasConcept C190612196 @default.
• W2020361785 hasConcept C203014093 @default.
• W2020361785 hasConcept C2776120307 @default.
• W2020361785 hasConcept C2776793103 @default.
• W2020361785 hasConcept C2777425658 @default.
• W2020361785 hasConcept C2778048844 @default.
• W2020361785 hasConcept C2778371730 @default.
• W2020361785 hasConcept C2780133432 @default.
• W2020361785 hasConcept C2780346216 @default.
• W2020361785 hasConcept C2781375639 @default.
• W2020361785 hasConcept C2908647359 @default.
• W2020361785 hasConcept C71924100 @default.
• W2020361785 hasConcept C761482 @default.
• W2020361785 hasConcept C86803240 @default.

• next